久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Sanofi targets ground-breaking therapies with a new R&D strategy

chinadaily.com.cn | Updated: 2022-03-31 11:04
Share
Share - WeChat
John Reed, executive vice-president, global head of research and development at Sanofi. [Photo provided to chinadaily.com.cn]

"We are sharpening our R&D focus on first-in-class or best-in-class medicines and vaccines in order to address the world's most urgent healthcare needs", said John Reed, executive vice-president and head of Global R&D of Sanofi. He emphasized Sanofi's scientific mission when talking about the company's R&D strategy, "because patients are counting on us."

Reed, formerly the head of Roche Pharma Research and Early Development (pRED), joined Sanofi in 2018, where he participated in and witnessed a crucial strategic transformation of the company.

As an essential step in Sanofi's "Play to Win" strategy, announced in 2019, the company launched a new brand identity and purpose to highlight its corporate mission "Chase the miracles of science to improve people's lives" early this year.

Companies that implement rebranding will often make key strategic adjustments, and Sanofi is no exception. As an R&D-driven pharmaceutical company, Sanofi has made the transformation of its R&D strategy central to its rebranding initiatives.

"The pursuit of scientific miracles is a dynamic process, and the process of R&D is challenging, but we don't let the setbacks deter us from pushing forward and working to improve the lives of patients," Reed said.

A new transformation, a new ambition

Founded in 1973, Sanofi is a young global pharmaceutical company. In the past several decades, it has developed many breakthrough therapies, including Lantus (insulin glargine), Taxotere (anti-cancer drug), Lovenox (anti-coagulant), Aubagio (multiple sclerosis), and Cerezyme (Gaucher disease).

For almost half a century, Sanofi has been protecting lives with its vaccines, saving and transforming lives with its cutting-edge science, from primary care to the treatment of cancer and rare diseases. It took Sanofi only 32 years to go from being a small company to being one of the top pharmaceutical giants in the world, an astonishingly rapid ascent compared with century-old pharmaceutical companies.

Despite such extraordinary past achievements, Sanofi is reflecting on the most urgent healthcare needs which have yet to be resolved. Can innovation and R&D be refocused? Can products have greater clinical value? How to sustain long-term growth? According to Reed, Sanofi has strictly prioritized and reallocated resources for R&D.

Based on its expertise and experience with preventing and treating conditions from chronic diseases to rare diseases, Sanofi further optimizes resources to sharpen its R&D focus to first-in-class or best-in-class programs in vaccines and specialty care areas like immunology and oncology, where recent breakthroughs open up a world of new therapeutic opportunities.

A sign of Sanofi's progress is that in 2021 it added 36 phase I and phase II clinical development programs, a clear indication of its strong pipeline of early-stage projects. The company is also investing more in biologics – seen in the fact that they now represent over 70 percent of its pipeline.

According to Reed, Sanofi has prioritized multiple potentially transformative therapies in areas of high unmet patient need, including Dupixent, the world's first targeted biological agent that has been approved for treating moderate-to-severe atopic dermatitis, Fitusiran and Efanesoctocog alfa (BIVV001) for treatment of hemophilia, Amlitelimab for treatment of inflammatory disorders, Amcenestrant for treatment of breast cancer, RSV Vaccine Nirsevimab, and Tolebrutinib for treatment of multiple sclerosis.

Sanofi's changes are also evident in its financial performance. In the newly released 2021 annual financial report, specialty medicine has become Sanofi's most prominent business unit by sales for the first time, with R&D investment in specialty drug products accounting for 95 percent of the company's total R&D investment, up by about 50 percent from that of 2017.

1 2 3 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    蜜臀av色欲a片无码精品一区 | 天堂在线中文在线| 亚洲精品蜜桃久久久久久| 天天爱天天操天天干| 亚洲五码在线观看视频| 一区二区三区国产免费| 97在线国产视频| 欧美亚洲视频一区| av网站在线不卡| 国产视频一视频二| 九九久久九九久久| 91高清国产视频| 能在线观看的av| 大荫蒂性生交片| 亚洲小视频网站| 欧美韩国日本在线| 丁香花在线影院观看在线播放| www.久久久久久久久久久| caopor在线视频| a√天堂在线观看| 国产一级做a爰片久久毛片男| 欧美视频亚洲图片| 天堂av在线网站| 欧美污视频网站| 青青草国产精品视频| 亚洲天堂第一区| 国产一级片中文字幕| 色一情一区二区| 青青草精品视频在线观看| 男人天堂999| 97超碰青青草| 免费无码不卡视频在线观看| 精品国偷自产一区二区三区| 黑人巨大国产9丨视频| 中文字幕第22页| 伊人国产精品视频| 九一精品久久久| 三区视频在线观看| 中文字幕线观看| 亚洲一区二区福利视频| 在线观看国产一级片| www.夜夜爽| 99re6在线观看| 在线视频观看91| 欧美国产日韩在线视频| 欧美视频国产视频| 国产黑丝在线视频| 亚洲色图欧美自拍| 国产欧美综合一区| 日本xxxxx18| 男人日女人的bb| 日本香蕉视频在线观看| a级免费在线观看| 青青青青草视频| 国产男女在线观看| 91日韩视频在线观看| 天天色综合社区| 亚洲自拍第三页| a级网站在线观看| 日本美女爱爱视频| 日本阿v视频在线观看| 精品少妇人妻av免费久久洗澡| 欧美一区二区中文字幕| 黑森林福利视频导航| 亚洲一区日韩精品| 麻豆中文字幕在线观看| 国产xxxx振车| 国产情侣av自拍| 亚洲一区精品视频在线观看| 亚洲国产精品女人| 欧美久久久久久久久久久久久| 999香蕉视频| 国产美女18xxxx免费视频| 熟女视频一区二区三区| 2018日日夜夜| 日韩av片网站| 天天干天天色天天爽| 免费一级特黄特色毛片久久看| 激情婷婷综合网| 日本特黄在线观看| 欧美 日韩 国产 高清| 免费看污黄网站| 米仓穗香在线观看| 国产真实乱子伦| www.色.com| 波多野结衣乳巨码无在线| 亚洲成人福利在线观看| 欧美少妇一区二区三区| 激情六月丁香婷婷| 中文字幕一区二区三区四区五区人 | 亚洲AV无码成人精品一区| 欧洲精品一区二区三区久久| 另类小说色综合| 日本免费a视频| 中文av一区二区三区| 妺妺窝人体色www看人体| 亚洲中文字幕久久精品无码喷水 | 高清在线观看免费| 中文字幕第17页| 欧美精品久久久久久久久久久| 五月婷婷激情久久| 久青草视频在线播放| 亚洲综合婷婷久久| 秋霞无码一区二区| 国产成年人在线观看| 99精品免费在线观看| 成人一区二区av| 亚洲国产精品三区| 激情深爱综合网| 看一级黄色录像| www.亚洲高清| 久久久一本二本三本| 91制片厂免费观看| 日韩肉感妇bbwbbwbbw| 日韩精品―中文字幕| 日本xxx免费| 手机av在线网| 国产精品少妇在线视频| 精品国偷自产一区二区三区| 久久精品一卡二卡| 亚洲一区二区蜜桃| 免费在线观看亚洲视频| av日韩在线看| 午夜一级免费视频| 粗暴91大变态调教| 日本中文字幕网址| www国产无套内射com| aaa一级黄色片| 国产九九热视频| 国产一区亚洲二区三区| 国产深夜男女无套内射| 福利在线一区二区| 特黄特黄一级片| 人人爽人人爽av| 182午夜在线观看| 一区二区三区国产免费| 国产男女激情视频| 国产在线青青草| 99热自拍偷拍| 国产二级片在线观看| 亚洲人成无码网站久久99热国产| 在线观看污视频| 日韩精品一区二区三区电影| 精品少妇人妻av一区二区| 亚洲一二三av| 色综合五月婷婷| 99精品视频国产| 天天久久综合网| 超碰91在线播放| xxx中文字幕| 日日噜噜噜夜夜爽爽| 最近中文字幕免费mv| 裸体大乳女做爰69| 可以在线看黄的网站| 国产女主播av| 国产91沈先生在线播放| 精品久久久久久无码中文野结衣| 国产欧美精品aaaaaa片| 欧日韩免费视频| 日日碰狠狠添天天爽超碰97| 久久国产成人精品国产成人亚洲 | 肉色超薄丝袜脚交| www.51色.com| 性欧美18一19内谢| 日韩视频 中文字幕| 国产成人亚洲综合无码| 奇米777四色影视在线看| 97超碰在线人人| 欧美 日韩 激情| 国产精彩免费视频| www.超碰97.com| 久久出品必属精品| 欧美一区二区三区综合| 亚洲国产精品无码观看久久| 日日鲁鲁鲁夜夜爽爽狠狠视频97| 国产成人久久婷婷精品流白浆| 男人搞女人网站| 日本77777| 大胆欧美熟妇xx| www黄色av| 亚洲精品第三页| www.国产二区| www.com毛片| 亚洲免费看av| 男人草女人视频| 男人天堂999| 亚洲综合激情视频| 成人av在线不卡| 四虎永久在线精品无码视频| 欧美成人乱码一二三四区免费| 欧美少妇在线观看| 97在线播放视频| 三级黄色片免费看| av免费观看大全| 成年网站免费在线观看| 久草视频国产在线| 亚洲色图久久久| 日韩欧美猛交xxxxx无码| 我要看一级黄色大片| 污污视频网站在线|